Nordic Nanovector ASA
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
Market Cap & Net Worth: Nordic Nanovector ASA (8NN)
Nordic Nanovector ASA (F:8NN) has a market capitalization of $145.80 Million (€142.04 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #21407 globally and #2323 in its home market, demonstrating a 9.56% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nordic Nanovector ASA's stock price €0.40 by its total outstanding shares 354220633 (354.22 Million).
Nordic Nanovector ASA Market Cap History: 2015 to 2026
Nordic Nanovector ASA's market capitalization history from 2015 to 2026. Data shows change from $521.40 Million to $145.80 Million (-10.39% CAGR).
Nordic Nanovector ASA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nordic Nanovector ASA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
9919.48x
Nordic Nanovector ASA's market cap is 9919.48 times its annual revenue
1728.56x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.80 Billion | $314.00K | -$235.51 Million | 12097.15x | N/A |
| 2017 | $3.00 Billion | $302.00K | -$293.81 Million | 9919.48x | N/A |
Competitor Companies of 8NN by Market Capitalization
Companies near Nordic Nanovector ASA in the global market cap rankings as of March 18, 2026.
Key companies related to Nordic Nanovector ASA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Nordic Nanovector ASA Historical Marketcap From 2015 to 2026
Between 2015 and today, Nordic Nanovector ASA's market cap moved from $521.40 Million to $ 145.80 Million, with a yearly change of -10.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €145.80 Million | -8.45% |
| 2025 | €159.26 Million | +100.00% |
| 2024 | €79.63 Million | +113.87% |
| 2023 | €37.23 Million | -0.10% |
| 2022 | €37.27 Million | -95.50% |
| 2021 | €827.55 Million | +53.58% |
| 2020 | €538.85 Million | -54.60% |
| 2019 | €1.19 Billion | -35.24% |
| 2018 | €1.83 Billion | -38.83% |
| 2017 | €3.00 Billion | -21.14% |
| 2016 | €3.80 Billion | +628.52% |
| 2015 | €521.40 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Nordic Nanovector ASA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $145.80 Million USD |
| MoneyControl | $145.80 Million USD |
| MarketWatch | $145.80 Million USD |
| marketcap.company | $145.80 Million USD |
| Reuters | $145.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.